Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study

Journal of the American Academy of Dermatology

Volumn 57, Issue 5, 2007, Pages 791-799

  Thiboutot, Diane M ^a   Weiss, Jonathan ^b   Bucko, Alicia ^c   Eichenfield, Lawrence ^d   Jones, Terry ^e   Clark, Scott ^f   Liu, Yin ^g   Graeber, Michael ^g   Kang, Sewon ^h  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Gwinnett Dermatology   (United States)

^c Academic Dermatology Associates   (United States)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e J and S Studies   (United States)

^f Longmont Clinic   (United States)

^g Galderma Research and Development   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ADAPALENE PLUS BENZOYL PEROXIDE; BENZOYL PEROXIDE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION;

ACNE VULGARIS; ADOLESCENT; ADULT; BENZOYL PEROXIDE; CHILD; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; TREATMENT OUTCOME;

EID: 35148853655     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.06.006     Document Type: Article

References (35)

1. Pawin H., Beylot C., Chivot M., Faure M., Poli F., Revuz J., et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 14 (2004) 4-12
2. Leyden J.J. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 49 Suppl (2003) S200-S210
3. Gollnick H., Cunliffe W., Berson D., Dreno B., Finlay A., Leyden J.J., et al. Management of acne. A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49 1 Suppl (2003) S1-S37
4. Gollnick H., and Schramm M. Topical drug treatment in acne. Dermatology 196 (1998) 119-125
5. Brogden R.N., and Goa K.L. Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 53 (1997) 511-519
6. Michel S., Jomard A., and Demarchez M. Pharmacology of adapalene. Br J Dermatol 139 52 Suppl (1998) 3-7
7. Vega B., Jomard A., and Michel S. Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene. [abstract]. J Eur Acad Dermatol Venereol 16 1 Suppl (2002) 123-124
8. Shroot B., and Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 36 Suppl (1997) S96-S103
9. Haider A., and Shaw J.C. Treatment of acne vulgaris. JAMA 292 (2004) 726-735
10. Cunliffe W.J., Poncet M., Loesche C., and Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol 139 (1998) 48-56
11. Waugh J., Noble S., and Scott L.J. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs 64 (2004) 1465-1478
12. Dosik J.S., Homer K., and Arsonnaud S. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%. Cutis 75 (2005) 289-293
13. Dosik J.S., Homer K., and Arsonnaud S. Cumulative irritation potential of adapalene 0.1% cream and gel compared to tretinoin micro sphere 0.04% and 0.1%. Cutis 75 (2005) 238-243
14. Greenspan A., Loesche C., Vendetti N., Georgeian K., Gilbert R., Poncet M., et al. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. Cutis 72 (2003) 76-81
15. Dunlap F.E., Mills O.H., Tuley M.R., Baker M.D., and Plott R.T. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference. Br J Dermatol 139 (1998) 17-22
16. Caron D., Sorba V., Kerrouche N., and Clucas A. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 36 Suppl (1997) S110-S112
17. Egan N., Loesche M.C., and Baker M.M. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis 68 4 Suppl (2001) 20-24
18. Brand B., Gilbert R., Baker M.D., Poncet M., Greenspan A., Georgeian K., et al. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol 49 3 Suppl (2003) S227-S232
19. Caron D., Sorba V., Clucas A., and Verschoore M. Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. J Am Acad Dermatol 36 Suppl (1997) S113-S115
20. Wolf Jr. J.E., Kaplan D., Kraus S.J., Loven K.H., Rist T., Swinyer L.J., et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. J Am Acad Dermatol 49 3 Suppl (2003) S211-S217
21. Cunliffe W.J., Meynadier J., Alirezai M., George S.A., Coutts I., Roseeuw D.I., et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 49 3 Suppl (2003) S218-S226
22. Zhang J., Li L., Tu Y., and Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 15 (2004) 372-378
23. Thiboutot D., Shalita A., Yamauchi P.S., Dawson C., Arsonnaud S., Kang S., et al. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skinmed 4 3 (2005) 138-146
24. Plewig G., and Kligman A.M. Acne and rosacea. 3rd ed. (2000), Springer-Verlag, New York
25. Leyden J.J. The evolving role of P acnes in acne. Semin Cutan Med Surg 20 (2001) 139-143
26. Bowman S., Gold M., Nasir A., and Vamvakias G. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. J Drugs Dermatol 4 (2005) 611-618
27. Bikowski J.B. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel as monotherapy and in combination. J Drugs Dermatol 4 (2005) 164-171
28. Lookingbill D.P., Chalker D.K., Lindholm J.S., Katz H.I., Kempers S.E., Huerter C.J., et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 37 (1997) 590-595
29. Martin B., Meunier C., Montels D., and Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol 139 52 Suppl (1998) 8-11
30. Mills Jr. O.H., Kligman A.M., Pochi P., and Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol 25 (1986) 664-667
31. Data on file. Galderma Laboratories.
32. Thiboutot D. New treatments and therapeutic strategies for acne. Arch Family Med 9 (2000) 179-187
33. Lavker R.M., Leyden J.J., and Thorne E.G. An ultrastructural study of the effects of topical tretinoin on microcomedones. Clin Ther 14 (1992) 773-780
34. Clindamycin/tretinoin. Drugs 6 (2005) 231-234
35. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. Drugs in Dermatol. In press.